These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 13642774)

  • 21. [Therapy in hepatic ascites].
    Knoblauch M
    Praxis (Bern 1994); 1995 May; 84(19):561-3. PubMed ID: 7792465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis.
    Arroyo V; Ginès P; Planas R
    Gastroenterol Clin North Am; 1992 Mar; 21(1):237-56. PubMed ID: 1568775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of ascites and hepatorenal syndrome.
    Piano S; Tonon M; Angeli P
    Hepatol Int; 2018 Feb; 12(Suppl 1):122-134. PubMed ID: 28836115
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strategies in the treatment of ascites.
    Schölmerich J
    Hepatogastroenterology; 1991 Oct; 38(5):365-70. PubMed ID: 1765352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. THE USE OF SPIRONOLACTONE AND LARGE DOSES OF STEROIDS IN THE TREATMENT OF ASCITES OF LIVER DISEASE.
    STERNBERG MS; HAGEDORN CW; KALSER MH
    South Med J; 1963 Nov; 56():1302-8. PubMed ID: 14078384
    [No Abstract]   [Full Text] [Related]  

  • 26. Preservation of nutritional-status in patients with refractory ascites due to hepatic cirrhosis who are undergoing repeated paracentesis.
    Sorrentino P; Castaldo G; Tarantino L; Bracigliano A; Perrella A; Perrella O; Fiorentino F; Vecchione R; D' Angelo S
    J Gastroenterol Hepatol; 2012 Apr; 27(4):813-22. PubMed ID: 22142548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hyponatremia in patients with ascites complicating liver cirrhosis].
    Xu Z; Jiang ZH
    Zhonghua Nei Ke Za Zhi; 1992 Oct; 30(10):628-30, 658-9. PubMed ID: 1582343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. To salt or not to salt?-That is the question in cirrhosis.
    Haberl J; Zollner G; Fickert P; Stadlbauer V
    Liver Int; 2018 Jul; 38(7):1148-1159. PubMed ID: 29608812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ascites and its delivery.
    Epstein FH
    N Engl J Med; 1970 Jun; 282(25):1431-2. PubMed ID: 5445530
    [No Abstract]   [Full Text] [Related]  

  • 30. High Dose Oral Furosemide with Salt Ingestion in the Treatment of Refractory Ascites of Liver Cirrhosis.
    Yakar T; Demir M; Dogan O; Parlakgumus A; Ozer B; Serin E
    Clin Invest Med; 2016 Dec; 39(6):27502. PubMed ID: 27917793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Sodium in clinics and complications of liver cirrhosis].
    Petrova D; Kolarski V; Todorov A
    Vutr Boles; 2000; 32(1):37-40. PubMed ID: 11195196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Compartmentalization of ascites and edema in patients with hepatic cirrhosis.
    Shear L; Ching S; Gabuzda GJ
    N Engl J Med; 1970 Jun; 282(25):1391-6. PubMed ID: 4910836
    [No Abstract]   [Full Text] [Related]  

  • 33. [The hyposmolar-hyponatremic syndrome in hepatic cirrhosis. Possible role of ADH].
    Cavatorta F; Brignole M; Queirolo C
    Minerva Med; 1979 Mar; 70(12):845-52. PubMed ID: 431839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DELIRIUM AND COMPLEX ELECTROLYTE DISTURBANCE.
    WOHLRABE JC; PITTS FN
    Dis Nerv Syst; 1965 Jan; 26():44-7. PubMed ID: 14248513
    [No Abstract]   [Full Text] [Related]  

  • 35. Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis.
    Salerno F; Guevara M; Bernardi M; Moreau R; Wong F; Angeli P; Garcia-Tsao G; Lee SS
    Liver Int; 2010 Aug; 30(7):937-47. PubMed ID: 20492521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Depletion therapy of chronic congestive heart failure].
    Sánchez A
    Rev Esp Cardiol; 1968 Apr; 21(2):234-73. PubMed ID: 4905456
    [No Abstract]   [Full Text] [Related]  

  • 37. Therapeutic approach to chronic electrolyte disorders.
    Willard M
    Vet Clin North Am Small Anim Pract; 2008 May; 38(3):535-41, x. PubMed ID: 18402879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial.
    Ginès P; Wong F; Watson H; Milutinovic S; del Arbol LR; Olteanu D;
    Hepatology; 2008 Jul; 48(1):204-13. PubMed ID: 18508290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Azotemia (48 h) decreases the risk of brain damage in rats after correction of chronic hyponatremia.
    Soupart A; Penninckx R; Stenuit A; Decaux G
    Brain Res; 2000 Jan; 852(1):167-72. PubMed ID: 10661508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrolyte disturbances and low-salt syndrome.
    STEELE JM
    N Y State J Med; 1953 Aug; 53(15):1766-9. PubMed ID: 13072860
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.